Antimicrobial resistance is recognised as one of the top threats healthcare is bound to face in the future. There have been various attempts to preserve the efficacy of existing …
H Liu, Y Xiang, M Xiong, X Xiao, J Zhou, H Tian… - Communications …, 2024 - nature.com
Infection caused by KPC and NDM carbapenemases co-producing Klebsiella pneumoniae (KPC_NDM_CRKP) poses serious public health concerns. Here, we elucidate the …
W Hsu, MH Chuang, WW Tsai, CC Lai, HY Lai… - Infection, 2024 - Springer
Background This meta-analysis was conducted to compare the efficacy of ceftazidime- avibactam combination therapy with that of monotherapy in the treatment of carbapenem …
This guideline aims to promote the prudent use of antibacterial agents for managing carbapenem-resistant Enterobacterales (CRE) infections in clinical practice in Korea. The …
L Zeng, J Ma, J Qiu, Q Ren, C Wei, N Cheng - 2024 - researchsquare.com
Purpose Infections caused by Carbapenem-resistant Klebsiella pneumoniae (CRKP) are increasing annually, with bloodstream infection (BSI) being a significant outcome associated …
P Paschke, I Miczek, M Sambura… - Journal of Education …, 2024 - apcz.umk.pl
Abstract Introduction: Infections caused by Klebsiella pneumoniae carbapenemase (KPC) pose a significant clinical challenge due to increasing antibiotic resistance. This study …
El incremento en la resistencia de los microorganismos a los tratamientos convencionales, debido al uso indiscriminado de los antibióticos en humanos, animales y plantas, es un …